Market Overview

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL)

2.46 -0.05 (-1.89%)

Earnings

QuarterPriorEstimateActualSurprise
Q2 2021
After-Hours
EPS:
REV:




Q1 2021
After-Hours
EPS:
REV:
0.13
55.761M



Q4 2020
After-Hours
EPS:
REV:
-0.10
15.4M



Q3 2020
After-Hours
EPS:
REV:
-0.07
9.141M



Q2 2020
After-Hours
EPS:
REV:
-0.12
10.407M
-0.13
13.75M
-0.10
16.021M
23.08%
16.52%
Q1 2020
After-Hours
EPS:
REV:
-0.11
12.624M
0.13
56.71M
0.13
55.761M
0%
-1.67%
Q4 2019
After-Hours
EPS:
REV:
0.02
37.857M
-0.08
15.62M
-0.10
15.4M
-25%
-1.41%
Q3 2019
After-Hours
EPS:
REV:
-0.14
4.865M
-0.13
11.95M
-0.07
20.857M
46.15%
74.54%
Q2 2019
After-Hours
EPS:
REV:
-0.16
1.787M
-0.14
9.28M
-0.12
10.407M
14.29%
12.14%
Q1 2019
After-Hours
EPS:
REV:
-0.17
0
-0.13
11.37M
-0.11
12.624M
15.38%
11.03%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!